Human Reproduction, Vol. 8, No. 5, pp. 705-709, 1993
© 1993 European Society of Human Reproduction and Embryology
other |
The effects of mifepristone (RU486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy
Medical Research Council Reproductive Biology Unit, University of Edinburgh Centre for Reproductive Biology 37 Chalmers Street, Edinburgh EH3 9EW 2Department of Obstetrics and Gynaecology, University of Edinburgh Centre for Reproductive Biology 37 Chalmers Street, Edinburgh EH3 9EW 3University of Edinburgh Department of Child Life and Health 17 Hatton Place, Edinburgh EH9 1UW, UK
Correspondence: 1To whom correspondence should be addressed
Prostaglandin dehydrogenase is the main inactivating enzyme for prostaglandins and therefore controls local levels of prostaglandins. Since there is some evidence that the expression of this enzyme is under progesterone control it is reasonable that one of the effects of antiprogestin is to reduce the concentration of this enzyme and thus increase the effective concentration of prostaglandin within tissue. We have investigated the amount of enzyme activity within decidua and chorionic villi from women receiving the antigestagen mifepristone (RU486) 12, 24 and 36 h prior to surgical abortion, and examined the effect on tissue concentrations of prostaglandin dehydrogenase. Women receiving mifepristone in all groups had a significant reduction in concentration of prostaglandin dehydrogenase enzyme in decidual tissue. There was also a marked reduction in prostaglandin dehydrogenase in decidual cells following RU486, as demonstrated by immunochemical methods. At this stage of pregnancy, prostaglandin dehydrogenase was present in abundance in cytotrophoblast cells of chorionic villi but virtually absent from syncytiotrophoblast. In chorionic villi after RU486 administration in vivo, there were no obvious differences in prostaglandin dehydrogenase distribution or reactivity in the majority of cases.
Key words: antiprogestins/chorionic villi/decidua/mifepristone/prostaglandin dehydrogenase
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley Endocrine Regulation of Menstruation Endocr. Rev., February 1, 2006; 27(1): 17 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Milne, T. A. Henderson, R. W. Kelly, P. T. Saunders, D. T. Baird, and H. O. D. Critchley Leukocyte Populations and Steroid Receptor Expression in Human First-Trimester Decidua; Regulation by Antiprogestin and Prostaglandin E Analog J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4315 - 4321. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hapangama, H. O. D. Critchley, T. A. Henderson, and D. T. Baird Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5229 - 5234. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.E. Roudebush, J.D. Wininger, A.E. Jones, G. Wright, A.A. Toledo, H.I. Kort, J.B. Massey, and D.B. Shapiro Embryonic platelet-activating factor: an indicator of embryo viability Hum. Reprod., May 1, 2002; 17(5): 1306 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye Endocrine and Paracrine Regulation of Birth at Term and Preterm Endocr. Rev., October 1, 2000; 21(5): 514 - 550. [Abstract] [Full Text] |
||||
![]() |
K. J. Greenland, I. Jantke, S. Jenatschke, K. E. Bracken, C. Vinson, and B. Gellersen The Human NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Gene Promoter Is Controlled by Ets and Activating Protein-1 Transcription Factors and Progesterone Endocrinology, February 1, 2000; 141(2): 581 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Marions and K. G. Danielsson Expression of cyclo-oxygenase in human endometrium during the implantation period Mol. Hum. Reprod., October 1, 1999; 5(10): 961 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. D. Critchley, R. L. Jones, R. G. Lea, T. A. Drudy, R. W. Kelly, A. R. W. Williams, and D. T. Baird Role of Inflammatory Mediators in Human Endometrium during Progesterone Withdrawal and Early Pregnancy J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 240 - 248. [Abstract] [Full Text] |
||||
![]() |
F. A. Patel, V. L. Clifton, K. Chwalisz, and J. R. G. Challis Steroid Regulation of Prostaglandin Dehydrogenase Activity and Expression in Human Term Placenta and Chorio-Decidua in Relation to Labor J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 291 - 299. [Abstract] [Full Text] |
||||
![]() |
K. E. Bracken, W. Elger, I. Jantke, A. Nanninga, and B. Gellersen Cloning of Guinea Pig Cyclooxygenase-2 and 15-Hydroxyprostaglandin Dehydrogenase Complementary Deoxyribonucleic Acids: Steroid-Modulated Gene Expression Correlates to Prostaglandin F2{alpha} Secretion in Cultured Endometrial Cells Endocrinology, January 1, 1997; 138(1): 237 - 247. [Abstract] [Full Text] [PDF] |
||||




